These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7810315)

  • 1. [Pharmacological economy: economic aspects and management of antibiotic therapy].
    Zanetti M
    Acta Otorhinolaryngol Ital; 1994; 14(3):245-7; discussion 301-5. PubMed ID: 7810315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic aspects of antibiotic therapy].
    Internist (Berl); 1996 Jul; 37(7 Suppl Okonomisch):1-8. PubMed ID: 9541671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological considerations in the economic evaluation of glycopeptides].
    García-Quetglas E; Sádaba B; Honorato J
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():68-73. PubMed ID: 9441326
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single daily dose and simplified dosing regimens as a method to improve antibiotic therapy.
    McDaniel A
    Pharm Pract Manag Q; 1996 Jul; 16(2):57-61. PubMed ID: 10161613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and quality considerations in antibiotic formulary management.
    Ritchie DF
    Pharm Pract Manag Q; 1996 Jul; 16(2):4-8. PubMed ID: 10161610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The other side of the coin: socioeconomic analysis of antibiotic resistance].
    García-Altés A; Jovell AJ; Aymerich M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():27-31. PubMed ID: 10605187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various aspects and current status of antibiotic therapy and chemotherapy of pulmonary tuberculosis in adults.
    DE MARTINI A
    Arch Maragliano Patol Clin; 1954; 9(4):863-72. PubMed ID: 13208392
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods of documenting cost savings associated with an antibiotic management program.
    Lacy MK; Eidem LA; Bond JA; Swartz MA
    Pharm Pract Manag Q; 1996 Jul; 16(2):66-70. PubMed ID: 10161615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic.
    Robinson JL; Hameed T; Carr S
    Clin Infect Dis; 2002 Jul; 35(1):26-31. PubMed ID: 12060871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategy for empirical antibiotic therapy re-evaluation: do you have to change a successful therapy?].
    Veber B
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):654-7. PubMed ID: 15234739
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria.
    Slama TG; Amin A; Brunton SA; File TM; Milkovich G; Rodvold KA; Sahm DF; Varon J; Weiland D;
    Am J Med; 2005 Jul; 118 Suppl 7A():1S-6S. PubMed ID: 15993671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
    Opmeer BC; El Moussaoui R; Bossuyt PM; Speelman P; Prins JM; de Borgie CA
    J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic therapy in developing countries].
    Carbon C
    Med Trop (Mars); 1999; 59(3):241-2. PubMed ID: 10701200
    [No Abstract]   [Full Text] [Related]  

  • 17. Modelling of escalating outpatient antibiotic expenditures.
    Zintzaras E; Ioannidis JP
    J Antimicrob Chemother; 2003 Dec; 52(6):1001-4. PubMed ID: 14585862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of prescribing treatment for respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2000 May; 6(8 Suppl):S419-26. PubMed ID: 10977481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of spontaneous medical utilization of antibiotics on the normal surgical ward--rationale and economic aspects].
    Schmidt-Matthiesen A; Schellmann J; Encke A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():854-60. PubMed ID: 9931739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.